Phocas Financial’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-24,634
Closed -$2.1M – 45
2026
Q2
$2.1M Buy
+24,634
New +$1.77M 0.29% 114

Other funds holding CYTK

Phocas Financial's CYTK Position: Q3 2026 in Review

Phocas Financial sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 24,634 shares — an estimated $2.1M sold.

Phocas Financial first reported a position in CYTK in Q2 2026 and held it in 1 quarter. The position peaked at $2.1M in Q2 2026. 468 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Phocas Financial reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial sold 24,634 Cytokinetics shares in Q3 2026, an estimated $2.1M.
  • Phocas Financial first reported a position in Cytokinetics in Q2 2026 and held it in 1 quarter.
  • Phocas Financial's Cytokinetics position peaked at $2.1M in Q2 2026.
  • 468 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Phocas Financial's 13F filing for Q3 2026.